What impact do side effects have on elderly chronic myeloid leukemia (CML) patients?
A decade of advances in multiple myeloma and unanswered questions
Biosimilars - the question of trials and approval
What are the economics of treating CLL?
COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costs
Arnon Nagler et al.